Leef Brands (LEEEF) Assets Average (2026)
Leef Brands (LEEEF) posted Assets Average of $39.1 million for Q1 2026.
Leef Brands (LEEEF) Assets Average (2026) Analysis & Trends
Leef Brands has reported Assets Average for 1 years, with the latest figure at $39.1 million in Q1 2026.
- Quarterly Assets Average changed N/A year-over-year to $39.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.1 million (changed N/A YoY) and the FY2025 annual result came in at $39.7 million, changed N/A from the prior year.
- Assets Average was little changed at $39.1 million in Q1 2026 per LEEEF's latest filing.
- Over five years, Assets Average peaked at $39.1 million in Q1 2026 and troughed at $39.1 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 5.97 Bn |
| 10 | Leef Brands | 59.45 Mn | 54.50 Mn | 2.41 Mn | 47.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.13 Mn |
| Mar 31, 2026 | 39.13 Mn |